Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide

Biological Chemistry

Volumn 380, Issue 11, 1999, Pages 1287-1294

  Kushev, Daniel ^a   Gorneva, Galina ^a   Taxirov, Svetoslav ^a   Spassovska, Nadejda ^a   Grancharov, Konstantin ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Bulgaria)

Author keywords

Antitumor activity; Apoptosis; Cytotoxicity; Platinum complexes

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPENTANE DERIVATIVE; HYDRAZIDE DERIVATIVE; PLATINUM DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LEUKEMIA CELL LINE; LEUKEMIA L 1210; LEWIS CARCINOMA; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALIA; MURINAE;

EID: 0032738549     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.164     Document Type: Article

References (26)

1. Barry, M.A., Behnke, C.A., and Eastman, A. (1990). Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hypertermia. Biochem. Pharmacol. 40, 2353-2362.
2. Bitha, P., Carvajal, S.G., Citarella, R.V., Delos Santos, E.F., Durr, F.E., Hlavka, J.J., Lang, S.A., Jr., Lindsay, H.L., Thomas, J.P., Wallace, R.E., and Lin, Y. (1989). A new family of water-soluble, third generation antitumor platinum complexes. J. Med. Chem. 32, 2063-2068.
3. Burchenal, J.H., Irani, G., Kern, K., Lokys, L., Turkevich, J. (1980). 1,2-diaminocyclohexane platinum derivatives of potential clinical value. Rec. Res. Cancer Res. 74, 146-155.
4. 2]. Indian J. Chem. 8, 193-194.
5. Dodoff, N., Grancharov, K., Gugova, R., and Spassovska, N. (1994). Platinum(II) complexes of benzole- and 3-methoxybenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect. J. Inorg. Biochem. 54, 221-233.
6. Dodoff, N., Grancharov, K., and Spassovska, N. (1995). Platinum(II) complexes of 4-methoxy- and 4-chlorobenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect. J. Inorg. Biochem. 60, 257-266.
7. Evans, D.L., Tilby, M., and Dive, C. (1994). Differential sensitivity to the introduction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res. 54, 1596-1603.
8. Fairbairn, D.W., and O'Neill, K.L. (1996). The neutral comet assay is sufficient to identify an apoptotic 'window' by visual inspection. Apoptosis 1, 91-94.
9. Fairbairn, D.W., Olive P.L., and O'Neill, K.L. (1995). The comet assay: A comprehensive review. Mutat. Res. 339, 37-59.
10. Gorzyca, W., Gong, J., Ardelt, B., Traganos, F., and Darzynkiewicz, Z. (1993). The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 53, 3186-3192.
11. Grancharov, K.C., Koch, M., Volm, M., and Kolar, G.F. (1988). Synthesis and cytotoxic effects of hydroxymethyl-3-pyridyl- and 2-chloro-5-pyridyltriazene derivatives. Cancer Lett. 41, 271-279.
12. Harrap, K.R., Jones, M., Wilkinson, C.R. (1980). Cisplatin: Current Status and New Developments. (New York: Academic Press), pp.193-212.
13. 15N coupling constants. J. Chem. Soc., Chem. Commun. 23, 861-865.
14. Kharitonov, Yu. Ya., Machkhoshvili, R.I., Kravchenko, A.N., and Shchelokov, R.I. (1975). Platinum(II) complex compounds with methoxybenzoylhydrazine isomers. Koord. Khim. 1(3), 323-332.
15. Kushev, D.N., Spassovska, N.C., Taxirov, S.I., and Grancharov, K.C. (1997). Cytotoxicity and antitumor activity of platinum(II) complexes of aromatic and cycloalkanecarboxylic acid hydrazides. Z. Naturforsch. 52c, 49-54.
16. McKeage, M.J., Higgins, J.D., and Kelland, L.R. (1991). Platinum and other metal coordination compounds in cancer chemotherapy - A commentary on the sixth international symposium - San Diego, California, 23-26 January 1991. Br. J. Cancer 64, 788-793.
17. Mellor, J.W. (1957). A Comprehensive Treatise on Inorganic and Theoretical Chemistry (London, UK: Longmans), pp. 375-385.
18. Muir, M., Cadiz, M., and Baez, A. (1988). Synthesis and characterization of new platinum(II) complexes containing thiazole and imidazole donors. Inorg. Chim. Acta. 151, 209-213.
19. Olive, P.L., Wlodek, D., Banath, J.P. (1991). Factors influencing DNA double-strand breaks measured in individual cells subjected to gel electrophoresis. Cancer Res. 51, 4671-4676.
20. Rutner, H., Lewin, N., Woodbury, E.C., McBride, T.J., and Rao, K. V. (1974). Antitumor activity of some acylhydrazines. Cancer Chemother. Rep. Part 1, 58, 803-810.
21. Sherman, S.E., and Lippard, S.J. (1987). Structural aspects of platinum anticancer drug interactions with DNA. Chem.Rev. 87, 1153-1181.
22. Spassovska, N.C., Bonchev, P.R., Grancharov, K.C., and Golovinsky, E.V. (1981). Method for synthesis of cis-diammine-dichloroplatinum(II). Bulgarian Patent No 54667.
23. Takahara, P.M., Rosenzweig, A.C., Frederick, C.A., and Lippard, S.J. (1995). Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377, 649-652.
24. Vodenicharov, M., Markova, D., and Djondjurov, L. (1996a). Isolation of chromatin fragments released by apoptotic cells. Cancer Letters 106, 51-58.
25. Vodenicharov, M., Markova, D., and Djondjurov, L. (1996b). The spontaneous apoptosis in Friend erythroleukemia cells induces a nonrandom fragmentation of DNA. DNA Cell Biol. 15, 287-296.
26. Yale, H., Losee, K., Martins, J., Holsing, M., Perry, F., and Bernstein, J. (1953). Chemotherapy of experimental tuberculosis. VIII. The synthesis of acid hydrazides, their derivatives and related compounds. J. Am. Chem. Soc. 75, 1933-1942.